| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Departments of Obstetrics and Gynecology [M. A. A., S. V. S.] and Clinical Pathology [V-M. K.], Kuopio University Hospital, and Departments of Anatomy [R. H. T., M. I. T.] and Pathology and Forensic Medicine [M. A. A., K. J. S., V-M. K.], University of Kuopio, FIN-70211 Kuopio, Finland
Several malignant tumors accumulate hyaluronan, a matrix component suggested to promote cancer cell migration and growth. To explore the potential clinical importance of this concept, we assessed the hyaluronan levels in epithelial ovarian cancer. A biotinylated affinity probe specific for hyaluronan was prepared and applied to histological sections of 309 epithelial ovarian cancers and 45 matched metastatic lesions. The staining was scored according to the percentage area of strong hyaluronan signal of total peri- and intratumoral stroma as low (<35%), moderate (35–75%), or high (>75%). Low, moderate, and high levels of stromal hyaluronan were observed in 95, 116, and 98 carcinomas, respectively. The high stromal hyaluronan level was significantly associated with poor differentiation, serous histological type, advanced stage, and large primary residual tumor, whereas it was not correlated with high CD44 expression on cancer cells. The 5-year outlook of the disease deteriorated with increasing stromal hyaluronan levels for both overall (45% versus 39% versus 26%; P = 0.002) and recurrence-free (66% versus 56% versus 40%; P = 0.008) survival. High levels of stromal hyaluronan were more frequent in metastatic lesions than in primary tumors (z = -3.9; P = 0.0001). In Cox’s multivariate analyses, high level of stromal hyaluronan was an independent prognostic factor in all patients, as well as in stage-specific subgroups. These results suggest that stromal hyaluronan accumulation may be a powerful enhancer of tumor progression and, as such, provides a novel, independent prognostic marker and a potential target of therapy.
This article has been cited by other articles:
|
|
 |
|
  A. Ghosh, H. Kuppusamy, and L. M. Pilarski Aberrant Splice Variants of HAS1 (Hyaluronan Synthase 1) Multimerize with and Modulate Normally Spliced HAS1 Protein: A POTENTIAL MECHANISM PROMOTING HUMAN CANCER J. Biol. Chem., July 10, 2009; 284(28): 18840 - 18850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Becker, W. F. Bergfeld, D. V. Belsito, C. D. Klaassen, J. G. Marks Jr, R. C. Shank, T. J. Slaga, P. W. Snyder, Cosmetic Ingredient Review Expert Panel, and F. A. Andersen Final Report of the Safety Assessment of Hyaluronic Acid, Potassium Hyaluronate, and Sodium Hyaluronate International Journal of Toxicology, July 1, 2009; 28(4_suppl): 5 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Webber, R. H. Jenkins, S. Meran, A. Phillips, and R. Steadman Modulation of TGF{beta}1-Dependent Myofibroblast Differentiation by Hyaluronan Am. J. Pathol., July 1, 2009; 175(1): 148 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Ivanova, C. M.V. Goparaju, S. V. Ivanov, D. Nonaka, C. Cruz, A. Beck, F. Lonardo, A. Wali, and H. I. Pass Protumorigenic Role of HAPLN1 and Its IgV Domain in Malignant Pleural Mesothelioma Clin. Cancer Res., April 15, 2009; 15(8): 2602 - 2611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Webber, S. Meran, R. Steadman, and A. Phillips Hyaluronan Orchestrates Transforming Growth Factor-{beta}1-dependent Maintenance of Myofibroblast Phenotype J. Biol. Chem., April 3, 2009; 284(14): 9083 - 9092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-S. Kim, H.-J. Kwak, J.-W. Lee, H.-J. Kim, M.-J. Park, J.-B. Park, K.-H. Choi, H. Yoo, S.-H. Shin, W.-S. Shin, et al. 17-Allylamino-17-Demethoxygeldanamycin Down-Regulates Hyaluronic Acid-Induced Glioma Invasion by Blocking Matrix Metalloproteinase-9 Secretion Mol. Cancer Res., November 1, 2008; 6(11): 1657 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-M. Kuang, Q. Zhao, J. Xu, J.-P. Yun, C. Wu, and L. Zheng Tumor-Educated Tolerogenic Dendritic Cells Induce CD3{epsilon} Down-Regulation and Apoptosis of T Cells through Oxygen-Dependent Pathways J. Immunol., September 1, 2008; 181(5): 3089 - 3098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Kyosseva, E. N. Harris, and P. H. Weigel The Hyaluronan Receptor for Endocytosis Mediates Hyaluronan-dependent Signal Transduction via Extracellular Signal-regulated Kinases J. Biol. Chem., May 30, 2008; 283(22): 15047 - 15055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Misra, L. M. Obeid, Y. A. Hannun, S. Minamisawa, F. G. Berger, R. R. Markwald, B. P. Toole, and S. Ghatak Hyaluronan Constitutively Regulates Activation of COX-2-mediated Cell Survival Activity in Intestinal Epithelial and Colon Carcinoma Cells J. Biol. Chem., May 23, 2008; 283(21): 14335 - 14344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Jokela, M. Jauhiainen, S. Auriola, M. Kauhanen, R. Tiihonen, M. I. Tammi, and R. H. Tammi Mannose Inhibits Hyaluronan Synthesis by Down-regulation of the Cellular Pool of UDP-N-acetylhexosamines J. Biol. Chem., March 21, 2008; 283(12): 7666 - 7673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Meran, D. W. Thomas, P. Stephens, S. Enoch, J. Martin, R. Steadman, and A. O. Phillips Hyaluronan Facilitates Transforming Growth Factor-{beta}1-mediated Fibroblast Proliferation J. Biol. Chem., March 7, 2008; 283(10): 6530 - 6545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-M. Kuang, Y. Wu, N. Chen, J. Cheng, S.-M. Zhuang, and L. Zheng Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes Blood, July 15, 2007; 110(2): 587 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Y. W. Bourguignon, E. Gilad, and K. Peyrollier Heregulin-mediated ErbB2-ERK Signaling Activates Hyaluronan Synthases Leading to CD44-dependent Ovarian Tumor Cell Growth and Migration J. Biol. Chem., July 6, 2007; 282(27): 19426 - 19441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hosono, Y. Nishida, W. Knudson, C. B. Knudson, T. Naruse, Y. Suzuki, and N. Ishiguro Hyaluronan Oligosaccharides Inhibit Tumorigenicity of Osteosarcoma Cell Lines MG-63 and LM-8 in Vitro and in Vivo via Perturbation of Hyaluronan-Rich Pericellular Matrix of the Cells Am. J. Pathol., July 1, 2007; 171(1): 274 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Gianoukakis, T. A. Jennings, C. S. King, C. E. Sheehan, N. Hoa, P. Heldin, and T. J. Smith Hyaluronan Accumulation in Thyroid Tissue: Evidence for Contributions from Epithelial Cells and Fibroblasts Endocrinology, January 1, 2007; 148(1): 54 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kultti, K. Rilla, R. Tiihonen, A. P. Spicer, R. H. Tammi, and M. I. Tammi Hyaluronan Synthesis Induces Microvillus-like Cell Surface Protrusions J. Biol. Chem., June 9, 2006; 281(23): 15821 - 15828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K A Voutilainen, M A Anttila, S M Sillanpaa, K M Ropponen, S V Saarikoski, M T Juhola, and V-M Kosma Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer J. Clin. Pathol., May 1, 2006; 59(5): 460 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tzircotis, R. F. Thorne, and C. M. Isacke Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding J. Cell Sci., November 1, 2005; 118(21): 5119 - 5128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Edward, C. Gillan, D. Micha, and R.H. Tammi Tumour regulation of fibroblast hyaluronan expression: a mechanism to facilitate tumour growth and invasion Carcinogenesis, July 1, 2005; 26(7): 1215 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sussmann, M. Sarbia, J. Meyer-Kirchrath, R.M. Nusing, K. Schror, and J.W. Fischer Induction of Hyaluronic Acid Synthase 2 (HAS2) in Human Vascular Smooth Muscle Cells by Vasodilatory Prostaglandins Circ. Res., March 19, 2004; 94(5): 592 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zoltan-Jones, L. Huang, S. Ghatak, and B. P. Toole Elevated Hyaluronan Production Induces Mesenchymal and Transformed Properties in Epithelial Cells J. Biol. Chem., November 14, 2003; 278(46): 45801 - 45810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sillanpaa, M. A. Anttila, K. Voutilainen, R. H. Tammi, M. I. Tammi, S. V. Saarikoski, and V.-M. Kosma CD44 Expression Indicates Favorable Prognosis in Epithelial Ovarian Cancer Clin. Cancer Res., November 1, 2003; 9(14): 5318 - 5324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. J. Hiltunen, M. Anttila, A. Kultti, K. Ropponen, J. Penttinen, M. Yliskoski, A. T. Kuronen, M. Juhola, R. Tammi, M. Tammi, et al. Elevated Hyaluronan Concentration without Hyaluronidase Activation in Malignant Epithelial Ovarian Tumors Cancer Res., November 15, 2002; 62(22): 6410 - 6413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Rilla, M. J. Lammi, R. Sironen, K. Torronen, M. Luukkonen, V. C. Hascall, R. J. Midura, M. Hyttinen, J. Pelkonen, M. Tammi, et al. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes J. Cell Sci., September 15, 2002; 115(18): 3633 - 3643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Simpson, C. M. Wilson, and J. B. McCarthy Inhibition of Prostate Tumor Cell Hyaluronan Synthesis Impairs Subcutaneous Growth and Vascularization in Immunocompromised Mice Am. J. Pathol., September 1, 2002; 161(3): 849 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Toole Hyaluronan promotes the malignant phenotype Glycobiology, March 1, 2002; 12(3): 37R - 42R. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Toole, T. N. Wight, and M. I. Tammi Hyaluronan-Cell Interactions in Cancer and Vascular Disease J. Biol. Chem., February 8, 2002; 277(7): 4593 - 4596. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Karjalainen, R. H. Tammi, M. I. Tammi, M. J. Eskelinen, U. M. Agren, J. J. Parkkinen, E. M. Alhava, and V.-M. Kosma Reduced Level of CD44 and Hyaluronan Associated with Unfavorable Prognosis in Clinical Stage I Cutaneous Melanoma Am. J. Pathol., September 1, 2000; 157(3): 957 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Peterson, Q. Yu, I. Stamenkovic, and B. P. Toole Perturbation of Hyaluronan Interactions by Soluble CD44 Inhibits Growth of Murine Mammary Carcinoma Cells in Ascites Am. J. Pathol., June 1, 2000; 156(6): 2159 - 2167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Pienimaki, K. Rilla, C. Fulop, R. K. Sironen, S. Karvinen, S. Pasonen, M. J. Lammi, R. Tammi, V. C. Hascall, and M. I. Tammi Epidermal Growth Factor Activates Hyaluronan Synthase 2 in Epidermal Keratinocytes and Increases Pericellular and Intracellular Hyaluronan J. Biol. Chem., June 1, 2001; 276(23): 20428 - 20435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Simpson, J. Reiland, S. R. Burger, L. T. Furcht, A. P. Spicer, T. R. Oegema Jr., and J. B. McCarthy Hyaluronan Synthase Elevation in Metastatic Prostate Carcinoma Cells Correlates with Hyaluronan Surface Retention, a Prerequisite for Rapid Adhesion to Bone Marrow Endothelial Cells J. Biol. Chem., May 18, 2001; 276(21): 17949 - 17957. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
